文献速递颈动脉与弓上血管

症状性轻度颈动脉狭窄血运重建的结局:VQI数据库分析

Outcomes of Carotid Revascularization in Patients with Symptomatic Mildly Stenotic Carotid Disease.
PubMed 文献 · Ann Vasc Surg · 2026-09-04

基于VQI数据库2016至2024年2700例症状性轻度颈动脉狭窄(狭窄<50%)患者,比较CEA(66%)、TCAR(24%)与TFCAS(10%)的院内及1年卒中与死亡结局。多因素分析显示,轻度狭窄患者中TCAR院内卒中风险低于CEA和TFCAS;1年时TFCAS的无卒中生存最低。

要点

  • 症状性轻度狭窄患者中,TCAR院内卒中风险低于CEA(aOR=0.44)和TFCAS(aOR=0.28)。
  • CEA与TFCAS术后,轻度狭窄者院内卒中/死亡风险高于重度狭窄者(aOR分别为1.52和2.13)。
  • 1年随访中,轻度狭窄患者接受TFCAS的无卒中生存最低。

核心结论

  • 在症状性轻度颈动脉狭窄患者中,TCAR相较于CEA和TFCAS表现出更低的卒中/死亡发生率,是较优的微创选择。
  • 未来研究需纳入单纯药物治疗组以进一步确认上述发现并优化患者选择。

研究设计与样本

  • VQI数据库2016至2024年回顾性分析,纳入CEA、TCAR与TFCAS治疗的症状性轻度狭窄动脉粥样硬化病变患者,共2700例(CEA 66%、TFCAS 10%、TCAR 24%)。
  • 狭窄程度经双功超声分为轻度(<50%)、中度(50-69%)与重度(70-99%),主要结局为院内及1年卒中与死亡。
  • 采用Kaplan-Meier估计及logistic与Cox回归模型分析。

主要发现

  • 轻度狭窄患者中,TCAR院内卒中风险低于CEA(aOR=0.44,95%CI 0.21-0.93,P=0.03)和TFCAS(aOR=0.28,95%CI 0.11-0.69,P=0.006)。
  • 中度狭窄患者中三种术式的院内结局无显著差异。
  • 重度狭窄患者中,TFCAS院内卒中/死亡风险高于CEA(aOR=1.4,95%CI 1.03-1.85,P=0.03),TCAR与CEA相当(aOR=1.57,95%CI 0.76-3.27,P=0.2)。
  • CEA术后轻度狭窄较重度狭窄院内卒中/死亡风险更高(aOR=1.52,95%CI 1.09-2.08,P=0.014),TFCAS术后亦然(aOR=2.13,95%CI 1.14-4,P=0.018),TCAR术后无此差异(aOR=0.64,95%CI 0.31-1.28,P=0.208)。
  • 1年随访时,轻度狭窄患者中TFCAS的无卒中生存最低。

关键数值与推荐

  • 轻度狭窄定义为双功超声示狭窄<50%,中度50-69%,重度70-99%。
  • 轻度狭窄患者TCAR对比CEA的院内卒中aOR=0.44(95%CI 0.21-0.93,P=0.03)。
  • 轻度狭窄患者TCAR对比TFCAS的院内卒中aOR=0.28(95%CI 0.11-0.69,P=0.006)。
  • 重度狭窄患者TFCAS对比CEA的院内卒中/死亡aOR=1.4(95%CI 1.03-1.85,P=0.03)。

临床怎么用

  • 对症状性轻度颈动脉狭窄需血运重建者,TCAR可能较CEA和TFCAS具有更低的院内卒中风险。
  • 应结合狭窄程度与术式评估风险,轻度狭窄行CEA或TFCAS时需警惕院内卒中/死亡风险可能高于重度狭窄。
  • 研究结果可为症状性轻度狭窄患者的术式选择提供参考,但需结合个体化评估。

局限性

  • 为VQI数据库回顾性分析,存在选择偏倚与未测量混杂的可能。
  • 缺乏单纯药物治疗对照组,无法比较血运重建与药物治疗的差异。
  • 仅纳入动脉粥样硬化性病变,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Medical therapy alone is widely considered effective for symptomatic low-grade (≤50%) carotid artery stenosis (SxLGS). While mildly stenotic plaques generally carry a lower stroke risk than moderate-to-severe stenotic plaques, advanced imaging has identified high-risk features, such as intraplaque hemorrhage and ulceration, which are associated with an increased stroke risk and necessitate intervention if symptomatic. The evidence regarding symptomatic low-grade carotid stenosis management remains unclear. We aim to investigate patients with SxLGS in the VQI database by evaluating postoperative outcomes following carotid endarterectomy (CEA), transcarotid artery revascularization (TCAR), and transfemoral carotid artery stenting (TFCAS). METHODS: This is a retrospective analysis of CEA, TCAR, and TFCAS done for SxLGS patients in the VQI database from 2016 to 2024. Atherosclerotic lesions were only included. The degree of stenosis was classified using duplex ultrasonography as follows: low-grade stenosis (LGS) (<50%), moderate-grade stenosis (MGS) (50-69%), and severe-grade stenosis (SGS) (70-99%). The primary outcomes were in-hospital and 1-year stroke and death, comparing the three procedures in each degree of stenosis cohort. Moreover, we conducted a subanalysis based on procedure type. Kaplan-Meier estimates, along with logistic and Cox regression models, were utilized for the analysis. RESULTS: A total of 2,700 patients with SxLGS (66% CEA, 10% TFCAS, and 24% TCAR) were identified. Multivariate analysis revealed that in patients with LGS, TCAR was linked to a lower risk of in-hospital stroke compared to CEA (adjusted odds ratio [aOR] = 0.44 [95% confidence interval [CI]: 0.21- 0.93]; P = 0.03) and TFCAS (aOR = 0.28 [95% CI: 0.11- 0.69]; P = 0.006). However, there was no significant difference among the three procedures in those with MGS. In SGS, TFCAS was linked to a higher risk of in-hospital stroke/death compared to CEA (aOR = 1.4[95% CI: 1.03-1.85]; P = 0.03), while TCAR and CEA were comparable (aOR = 1.57[95% CI: 0.76- 3.27]; P = 0.2). After comparing the three grades of carotid stenosis, we found that LGS was associated with a higher odds of in-hospital stroke/death compared to SGS following CEA (aOR = 1.52 [95% CI: 1.09-2.08]; P = 0.014) and TFCAS (aOR = 2.13 [95% CI: 1.14-4]; P = 0.018) but not TCAR (aOR = 0.64 [95% CI: 0.31-1.28]; P = 0.208). At 1 year, TFCAS was associated with the lowest stroke-free survival among patients with LGS. CONCLUSION: In this multi-institutional study, we reviewed outcomes of carotid revascularization in SxLGS patients. TCAR emerged as a superior minimally invasive option, showing a lower rate of stroke/death compared to both CEA and TFCAS. Future studies are required to confirm those findings and refine SxLGS patient selection by including a medical therapy-only arm.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Abdelkarim A, Kricfalusi M, Abdullah A, et al. Outcomes of Carotid Revascularization in Patients with Symptomatic Mildly Stenotic Carotid Disease. Ann Vasc Surg. 2026. PMID: 42697320. doi:10.1016/j.avsg.2026.08.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。